Genprex Inc (GNPX)

May 06, 2026

Top 3 Health Care Stocks That Are Set To Fly In Q2 - Benzinga

May 06, 2026

May 03, 2026

MSN Money - MSN

May 03, 2026

May 01, 2026

GNPX Forecast, Price Target & Analyst Ratings | GENPREX INC (NASDAQ:GNPX) - ChartMill

May 01, 2026

Apr 30, 2026

Genprex Secures Patent for Reqorsa Gene Therapy in Cancer Treatm - GuruFocus

Apr 30, 2026

Apr 30, 2026

Genprex Expands Reqorsa Cancer Therapy Patent Protection in Israel - TipRanks

Apr 30, 2026

Apr 30, 2026

Genprex, Inc. Files Form 8-K With SEC: Company Information, Nasdaq Listing, and Regulatory Details - Minichart

Apr 30, 2026

Apr 30, 2026

Genprex Receives Patent Grant from The Israel Patent Office for the Combination of Reqorsa® Gene Therapy and PD-1 Antibodies to Treat Cancer - BioSpace

Apr 30, 2026

Apr 30, 2026

Israel grants Genprex (NASDAQ: GNPX) patent for REQORSA lung cancer use - Stock Titan

Apr 30, 2026

Apr 29, 2026

Genprex (NASDAQ: GNPX) seeks approval for equity plan and reverse stock split - Stock Titan

Apr 29, 2026

Apr 29, 2026

Genprex collaborators to present diabetes gene therapy data at May meeting By Investing.com - Investing.com Australia

Apr 29, 2026

Apr 28, 2026

Genprex Collaborators to Present Positive Preclinical Data on Diabetes Gene Therapy for Type 2 Diabetes at the 2026 American Society of Gene and Cell Therapy Annual Meeting - BioSpace

Apr 28, 2026

Apr 28, 2026

Genprex collaborators to present diabetes gene therapy data at May meeting - Investing.com UK

Apr 28, 2026

Apr 28, 2026

average down - Moomoo

Apr 28, 2026

Apr 28, 2026

Genprex Highlights Promising Preclinical Data for Diabetes Gene Therapy - TipRanks

Apr 28, 2026

Apr 28, 2026

Genprex (GNPX) shows GPX-002 gene therapy reversed hyperglycemia in T2D mice - Stock Titan

Apr 28, 2026

Apr 24, 2026

GNPX Should I Buy - Intellectia AI

Apr 24, 2026

Apr 23, 2026

Genprex biomarker research selected for ASCO 2026 meeting By Investing.com - Investing.com India

Apr 23, 2026

Apr 22, 2026

Positive Clinical Data on Biomarkers in Patients Receiving Reqorsa® Gene Therapy To Be Released at the 2026 ASCO Annual Meeting - StreetInsider

Apr 22, 2026

Apr 22, 2026

Genprex biomarker research selected for ASCO 2026 meeting - Investing.com

Apr 22, 2026

Apr 22, 2026

Lung cancer gene therapy study lands ASCO slot with biomarker data - Stock Titan

Apr 22, 2026

Apr 22, 2026

Genprex Signs Sponsored Research Agreement to Study Biomarkers that May Predict Patient Response to Reqorsa® Gene Therapy - The Malaysian Reserve

Apr 22, 2026

Apr 22, 2026

Genprex signs research deal to study lung cancer biomarkers By Investing.com - Investing.com India

Apr 22, 2026

Apr 21, 2026

Genprex (GNPX) Partners with MD Anderson for Cancer Research - GuruFocus

Apr 21, 2026

Apr 21, 2026

Genprex enters research agreement with UT MD Anderson - TipRanks

Apr 21, 2026

Apr 21, 2026

Genprex (GNPX) Pops As Reqorsa Data Impresses At AACR 2026 - timothysykes.com

Apr 21, 2026

Apr 21, 2026

Genprex Expands Lung Cancer Gene Therapy Research Collaboration - TipRanks

Apr 21, 2026

Apr 21, 2026

Genprex signs research deal to study lung cancer biomarkers - Investing.com

Apr 21, 2026

Apr 21, 2026

Genprex enters MD Anderson research pact to study biomarkers for REQORSA in NSCLC and SCLC - TradingView

Apr 21, 2026

Apr 21, 2026

Genprex (NASDAQ: GNPX) expands MD Anderson pact and reports Reqorsa lung cancer trial progress - Stock Titan

Apr 21, 2026

Apr 21, 2026

Genprex presents preclinical lung cancer therapy data at AACR By Investing.com - Investing.com India

Apr 21, 2026

Apr 20, 2026

Genprex Collaborators Present Positive Preclinical Data on the Use of Reqorsa® Gene Therapy for the Treatment of Lung Cancer at the 2026 AACR Annual Meeting - The Malaysian Reserve

Apr 20, 2026

Apr 20, 2026

Genprex Collaborators Present Positive Preclinical Data on the U - GuruFocus

Apr 20, 2026

Apr 20, 2026

Genprex (GNPX) Reveals Promising Lung Cancer Research at AACR 20 - GuruFocus

Apr 20, 2026

Apr 20, 2026

Genprex presents preclinical lung cancer therapy data at AACR - Investing.com

Apr 20, 2026

Apr 20, 2026

Lung cancer gene therapy from Genprex shrank tumors, cleared some in mice - Stock Titan

Apr 20, 2026

Apr 20, 2026

Genprex Collaborators Present Positive Preclinical Data on the Use of Reqorsa® Gene Therapy for the Treatment of Lung Cancer at the 2026 AACR Annual Meeting (2026-04-20) - Seeking Alpha

Apr 20, 2026

Apr 17, 2026

Genprex | PRE 14A: Preliminary proxy statements relating to merger or acquisition - Moomoo

Apr 17, 2026

Apr 17, 2026

Genprex (NASDAQ: GNPX) asks shareholders to OK 1:5–1:50 reverse split, equity plan - Stock Titan

Apr 17, 2026

Apr 16, 2026

GNPX News | GENPREX INC (NASDAQ:GNPX) - ChartMill

Apr 16, 2026

Apr 15, 2026

Genprex director Longnecker sells shares worth $22 - Investing.com

Apr 15, 2026

Apr 15, 2026

Genprex director Longnecker sells shares worth $22 By Investing.com - Investing.com Australia

Apr 15, 2026

Apr 15, 2026

Genprex (GNPX) director logs small stock sales mainly for taxes - Stock Titan

Apr 15, 2026

Apr 13, 2026

GNPX Technical Analysis | Trend, Signals & Chart Patterns | GENPREX INC (NASDAQ:GNPX) - ChartMill

Apr 13, 2026

Apr 11, 2026

Surprises Report: What are the analyst revisions for Guess IncIs Genprex Inc stock a good investment in YEARWeekly Stock Analysis & Expert Approved Momentum Trade Ideas - baoquankhu1.vn

Apr 11, 2026